Search

Author/Creator Gomez Pardo, P

1. 199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study. (23rd October 2018)

Authors:
Prat, A; Adamo, B; Perez Fidalgo, J A; Blanch, S; Martinez, N; Gomez Pardo, P; López González, A; Murillo Juso, L; Amillano, K; Vidal, M; Pascual, T; Pare, L; Canes, J; Galvan, P; Gonzalez Farre, B; Ortega Cebrian, V; Gonzalez, X; Bellet Ezquerra, M; Villagrasa, P; Ciruelos, E M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 285PDBalixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial. (23rd October 2018)

Authors:
Cortes Castan, J; Martín, M; Pernas Simon, S; Gomez Pardo, P; Lopez-Tarruella, S; Gil Martin, M; Manso, L M; Ciruelos, E M; Perez Fidalgo, J A; Hernando, C; Ademuyiwa, F; Weilbaecher, K; Mayer, I A; Pluard, T; Martinez Garcia, M; Vahdat, L T; Wach, A; Barker, D; Romagnoli, B; Kaufman, P A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search